225 related articles for article (PubMed ID: 1517382)
1. Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists.
Jay N; Mansfield MJ; Blizzard RM; Crowley WF; Schoenfeld D; Rhubin L; Boepple PA
J Clin Endocrinol Metab; 1992 Sep; 75(3):890-4. PubMed ID: 1517382
[TBL] [Abstract][Full Text] [Related]
2. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
[TBL] [Abstract][Full Text] [Related]
3. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
[TBL] [Abstract][Full Text] [Related]
4. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
Pasquino AM; Pucarelli I; Accardo F; Demiraj V; Segni M; Di Nardo R
J Clin Endocrinol Metab; 2008 Jan; 93(1):190-5. PubMed ID: 17940112
[TBL] [Abstract][Full Text] [Related]
5. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
Poomthavorn P; Suphasit R; Mahachoklertwattana P
Gynecol Endocrinol; 2011 Aug; 27(8):524-8. PubMed ID: 21501002
[TBL] [Abstract][Full Text] [Related]
6. Review of outcomes after cessation of gonadotropin-releasing hormone agonist treatment of girls with precocious puberty.
Thornton P; Silverman LA; Geffner ME; Neely EK; Gould E; Danoff TM
Pediatr Endocrinol Rev; 2014 Mar; 11(3):306-17. PubMed ID: 24719967
[TBL] [Abstract][Full Text] [Related]
7. Effect of gonadotropin-releasing hormone analog on ovarian reserve in children with central precocious puberty.
Tao Y; Si C; Li H; Han J; Hou H; Yang M
Ann Palliat Med; 2020 Jan; 9(1):53-62. PubMed ID: 32005063
[TBL] [Abstract][Full Text] [Related]
8. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
[TBL] [Abstract][Full Text] [Related]
9. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.
Manasco PK; Pescovitz OH; Feuillan PP; Hench KD; Barnes KM; Jones J; Hill SC; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1988 Aug; 67(2):368-72. PubMed ID: 3292562
[TBL] [Abstract][Full Text] [Related]
10. Time to menarche and final height after histrelin implant treatment for central precocious puberty.
Gillis D; Karavani G; Hirsch HJ; Strich D
J Pediatr; 2013 Aug; 163(2):532-6. PubMed ID: 23485026
[TBL] [Abstract][Full Text] [Related]
11. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
[TBL] [Abstract][Full Text] [Related]
12. Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty.
Palmert MR; Mansfield MJ; Crowley WF; Crigler JF; Crawford JD; Boepple PA
J Clin Endocrinol Metab; 1999 Dec; 84(12):4480-8. PubMed ID: 10599706
[TBL] [Abstract][Full Text] [Related]
13. Adult height in precocious puberty after long-term treatment with deslorelin.
Oerter KE; Manasco P; Barnes KM; Jones J; Hill S; Cutler GB
J Clin Endocrinol Metab; 1991 Dec; 73(6):1235-40. PubMed ID: 1955504
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study.
Magiakou MA; Manousaki D; Papadaki M; Hadjidakis D; Levidou G; Vakaki M; Papaefstathiou A; Lalioti N; Kanaka-Gantenbein C; Piaditis G; Chrousos GP; Dacou-Voutetakis C
J Clin Endocrinol Metab; 2010 Jan; 95(1):109-17. PubMed ID: 19897682
[TBL] [Abstract][Full Text] [Related]
15. The histrelin implant: a novel treatment for central precocious puberty.
Hirsch HJ; Gillis D; Strich D; Chertin B; Farkas A; Lindenberg T; Gelber H; Spitz IM
Pediatrics; 2005 Dec; 116(6):e798-802. PubMed ID: 16322137
[TBL] [Abstract][Full Text] [Related]
16. Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty.
Mansfield MJ; Rudlin CR; Crigler JF; Karol KA; Crawford JD; Boepple PA; Crowley WF
J Clin Endocrinol Metab; 1988 Jan; 66(1):3-9. PubMed ID: 2961786
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height.
Lazar L; Kauli R; Pertzelan A; Phillip M
J Clin Endocrinol Metab; 2002 May; 87(5):2090-4. PubMed ID: 11994346
[TBL] [Abstract][Full Text] [Related]
18. Anovulation after precocious pubarche: early markers and time course in adolescence.
Ibáñez L; de Zegher F; Potau N
J Clin Endocrinol Metab; 1999 Aug; 84(8):2691-5. PubMed ID: 10443661
[TBL] [Abstract][Full Text] [Related]
19. Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty.
Weise M; Flor A; Barnes KM; Cutler GB; Baron J
J Clin Endocrinol Metab; 2004 Jan; 89(1):103-7. PubMed ID: 14715835
[TBL] [Abstract][Full Text] [Related]
20. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
Pasquino AM; Municchi G; Pucarelli I; Segni M; Mancini MA; Troiani S
J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
